Last year's Budget set aside £2.1 billion for NHS IT, and the autumn statement confirmed the capital is still there, but it looks like most of the money is headed for Frontline Digitisation. The Highland Marketing advisory board considers how this pattern of putting money into health tech, taking it out again, shaking up the badging, and starting over impacts the market. 
Healthcare professionals at one of the world's leading children's hospitals will benefit from digital imaging tools that will enhance how they assess x-rays, CTs, MRIs and other scans that are crucial for effective diagnoses.
Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH) will deploy an enterprise imaging solution, including a picture archiving and communication system (PACS), from medical imaging technology provider Sectra.
Black Country Pathology Services has seen its "biggest go-live to date" with the Clinisys laboratory information system that is being rolled-out to all of its laboratories.
The Dudley lab had a successful “big bang” go-live with WinPath Enterprise at the end of September and went-live with the Clinisys Integrated Clinical Environment, or ICE, at the same time.
Bayer moves ahead with the advancement of its comprehensive Radiology portfolio with progress on the development pipeline of new contrast agents as well as further partnerships in its digital business. The company announced today the presentation of new early clinical data for gadoquatrane, Bayer’s novel macrocyclic gadolinium-based compound currently in Phase II development, at the Radiological Society of North America (RSNA) Annual Meeting. NHS patients throughout the West Midlands are to benefit from a digital pathology programme, designed to help reduce cancer backlogs, transform services, and improve the speed and accuracy of cancer diagnosis.
As one of the largest digital pathology programmes in Europe, the West Midlands Cancer Alliance initiative covers a population of 5.8 million people across four NHS pathology networks and 17 NHS trusts.
Digital speech biomarker company ki:elements has published validation results on the use of its ki:e speech biomarker for cognition (SB-C) in early Alzheimer’s disease in the "Karger - Digital Biomarkers" journal.(1)
Two European dementia studies - the Dutch DeepSpA study in collaboration with Maastricht University & the Scottish SPeAK study in collaboration with University of Edinburgh - helped to validate the psychometric properties of the SB-C.